Charles N. York II - 18 Jul 2022 Form 4 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
COO, CFO and Secretary
Signature
/s/ Charles N. York II
Issuer symbol
DAWN
Transactions as of
18 Jul 2022
Net transactions value
-$50,000
Form type
4
Filing time
20 Jul 2022, 18:18:38 UTC
Previous filing
12 Jul 2022
Next filing
05 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DAWN Common Stock Sale $50,000 -2,500 -0.75% $20.00 331,365 18 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2021.